Ten-Year Change in Plasma Amyloid {beta} Levels and Late-Life Cognitive Decline
Okereke et al.
Arch Neurol 2009;66:1247-1253.
ABSTRACT
| FULL TEXT
Plasma {beta}-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype
Gomis et al.
Stroke 2009;40:3197-3201.
ABSTRACT
| FULL TEXT
Association of plasma amyloid {beta} with risk of dementia: The prospective Three-City Study
Lambert et al.
Neurology 2009;73:847-853.
ABSTRACT
| FULL TEXT
Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy
Kimberly et al.
Neurology 2009;72:1230-1235.
ABSTRACT
| FULL TEXT
Plasma A{beta}, homocysteine, and cognition: The Vitamin Intervention for Stroke Prevention (VISP) trial
Viswanathan et al.
Neurology 2009;72:268-272.
ABSTRACT
| FULL TEXT
Dementia of the Alzheimer Type
Jalbert et al.
Epidemiol Rev 2008;30:15-34.
ABSTRACT
| FULL TEXT
Peripheral A{beta} subspecies as risk biomarkers of Alzheimer's disease
Schupf et al.
Proc. Natl. Acad. Sci. USA 2008;105:14052-14057.
ABSTRACT
| FULL TEXT
Biochemical markers in persons with preclinical familial Alzheimer disease
Ringman et al.
Neurology 2008;71:85-92.
ABSTRACT
| FULL TEXT
The Clinical Significance of Plasmatic Amyloid A{beta}-40 Peptide Levels in Alzheimer's Disease Patients Treated With Galantamine
Modrego et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2008;23:286-290.
ABSTRACT
Plasma Amyloid {beta}-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer Disease
Locascio et al.
Arch Neurol 2008;65:776-785.
ABSTRACT
| FULL TEXT
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
Lopez et al.
Neurology 2008;70:1664-1671.
ABSTRACT
| FULL TEXT
Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?
Sun et al.
Arch Gen Psychiatry 2008;65:542-550.
ABSTRACT
| FULL TEXT
Complement-Associated Deposits in the Human Retina
Seth et al.
IOVS 2008;49:743-750.
ABSTRACT
| FULL TEXT
Plasma {beta} Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men: A Prospective, Population-Based Cohort Study
Sundelof et al.
Arch Neurol 2008;65:256-263.
ABSTRACT
| FULL TEXT
Association of Low Plasma Abeta42/Abeta40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease
Graff-Radford et al.
Arch Neurol 2007;64:354-362.
ABSTRACT
| FULL TEXT
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF {beta}-amyloid, and h-tau.
Squitti et al.
Neurology 2006;67:76-82.
ABSTRACT
| FULL TEXT
Effect of apolipoprotein e on the cerebral load of latent herpes simplex virus type 1 DNA.
Burgos et al.
J. Virol. 2006;80:5383-5387.
ABSTRACT
| FULL TEXT
Differential modulation of plasma {beta}-amyloid by insulin in patients with Alzheimer disease
Kulstad et al.
Neurology 2006;66:1506-1510.
ABSTRACT
| FULL TEXT
Interaction of the Cytosolic Domains of sorLA/LR11 with the Amyloid Precursor Protein (APP) and beta-Secretase beta-Site APP-Cleaving Enzyme
Spoelgen et al.
J. Neurosci. 2006;26:418-428.
ABSTRACT
| FULL TEXT
Plasma {beta}-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
Gurol et al.
Neurology 2006;66:23-29.
ABSTRACT
| FULL TEXT
Association of homocysteine with plasma amyloid {beta} protein in aging and neurodegenerative disease
Irizarry et al.
Neurology 2005;65:1402-1408.
ABSTRACT
| FULL TEXT
Autoantibodies to Redox-modified Oligomeric A{beta} Are Attenuated in the Plasma of Alzheimer's Disease Patients
Moir et al.
J. Biol. Chem. 2005;280:17458-17463.
ABSTRACT
| FULL TEXT